Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.
Publication
, Journal Article
Boutzoukas, AE; Benjamin, DK; Zimmerman, KO
Published in: Pediatrics
May 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pediatrics
DOI
EISSN
1098-4275
Publication Date
May 2021
Volume
147
Issue
5
Location
United States
Related Subject Headings
- Preliminary Data
- Pediatrics
- Humans
- Alanine
- Adenosine Monophosphate
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Boutzoukas, A. E., Benjamin, D. K., & Zimmerman, K. O. (2021). Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use. Pediatrics, 147(5). https://doi.org/10.1542/peds.2021-050212
Boutzoukas, Angelique E., Daniel K. Benjamin, and Kanecia O. Zimmerman. “Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.” Pediatrics 147, no. 5 (May 2021). https://doi.org/10.1542/peds.2021-050212.
Boutzoukas AE, Benjamin DK, Zimmerman KO. Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use. Pediatrics. 2021 May;147(5).
Boutzoukas, Angelique E., et al. “Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.” Pediatrics, vol. 147, no. 5, May 2021. Pubmed, doi:10.1542/peds.2021-050212.
Boutzoukas AE, Benjamin DK, Zimmerman KO. Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use. Pediatrics. 2021 May;147(5).
Published In
Pediatrics
DOI
EISSN
1098-4275
Publication Date
May 2021
Volume
147
Issue
5
Location
United States
Related Subject Headings
- Preliminary Data
- Pediatrics
- Humans
- Alanine
- Adenosine Monophosphate
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences